| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/2005 | CN1186346C Thienopyrrolidinones |
| 01/26/2005 | CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors |
| 01/26/2005 | CN1186340C C10 carbonate substituted taxanes as antitumor agents |
| 01/26/2005 | CN1186339C Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 01/26/2005 | CN1186336C Prepn and application in preparing medicine of fraxinus general coumarin |
| 01/26/2005 | CN1186335C Process for obtaining HMG-CoA reductase inhibitors of high purity |
| 01/26/2005 | CN1186334C Pharmaceutical application of benzofuranone derivatives |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines |
| 01/26/2005 | CN1186326C Propane-1, 3-dione derivatives |
| 01/26/2005 | CN1186324C Condensed heteroaryl derivatives |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/26/2005 | CN1186097C Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor |
| 01/26/2005 | CN1186090C Liquid medicine for treating burn |
| 01/26/2005 | CN1186087C Chinese medical preparation for preventing and treating cardiovascular, cerebrovascular diseases and its preparation method |
| 01/26/2005 | CN1186086C Composition for preventing and treating milk cow from bateria disease |
| 01/26/2005 | CN1186079C Burn treating medicine powder |
| 01/26/2005 | CN1186073C Medicine for treating genital herpes and preparation process thereof |
| 01/26/2005 | CN1186050C Ointment for removing necrosis, promoting granulation and invigorating bone and its preparation |
| 01/26/2005 | CN1186043C Externally applied medicine for treating osteopathy and its preparation method |
| 01/26/2005 | CN1186042C Chinese medicine composition for treating AIDS and its preparation method |
| 01/26/2005 | CN1186034C Chinese medicine for treating burn and scald |
| 01/26/2005 | CN1186026C Application of hydroxyethyl puerarin in preparation of new medicine for curing cerebrovascular diseases |
| 01/26/2005 | CN1186025C Sodium foscarnet frozen dried preparation and process for preparing the same |
| 01/26/2005 | CN1186024C Monophasic contraceptive method and kit comprising combination of progesterone and estrogen |
| 01/26/2005 | CN1186023C Biphasic contraceptive method and kit comprising combination of progestin and estrogen |
| 01/26/2005 | CN1186022C Medicine for oral disease |
| 01/26/2005 | CN1186021C Antimicrobial composition |
| 01/26/2005 | CN1186020C Acylbenzoxazine for enhancing synaptic response(s) |
| 01/26/2005 | CN1186019C Method for increasing retinal blood flow |
| 01/26/2005 | CN1186018C Method for preparing nano linolenic acid emulsion |
| 01/26/2005 | CN1186017C Process for preparing medicine for preventing and curing diabetes, hyperlipemia and obesity |
| 01/26/2005 | CN1186016C Compound iron-copper intensified nutrient agent |
| 01/26/2005 | CN1186015C Traditional Chinese medicine compound oral sticking film for coronary heart disease and angina pectoris |
| 01/26/2005 | CN1186014C Multi-particulate pharmaceutical form with programmed and timed releasing and preparation method thereof |
| 01/26/2005 | CN1186013C Peroral medicine deliver controlled system providing temporal and spatial control |
| 01/26/2005 | CN1186009C Pharmaceutical composition for dymenorrhea and premature labor |
| 01/26/2005 | CN1185957C Skin-care agent, health and face-care foodstuff |
| 01/26/2005 | CN1185934C Disinfectant lotion for vulva and vagina of human body |
| 01/25/2005 | US6846958 Synthesis of benzimidate from benzoic acid |
| 01/25/2005 | US6846957 After Claisen condensation of acetophenone with ethyl formate, condensing product with methylamine hydrochloride, converting that product with sodium borohydride and acetic acid to 3-methylamino-1-phenyl-1-propanol, to fluoxetine hydrochloride |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846953 Treating central nervous system disorders such as pain, depression, anxiety, schizophrenia, Huntington's disease, Alzheimer's disease or amyotrophic lateral sclerosis |
| 01/25/2005 | US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 01/25/2005 | US6846933 Antimycobacterial compounds and method for making the same |
| 01/25/2005 | US6846931 Organic acid salt of amlodipine |
| 01/25/2005 | US6846930 Antiinflammatory agents; antiarthritic agents; rheumatic diseases; anticancer agents |
| 01/25/2005 | US6846911 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit |
| 01/25/2005 | US6846907 Osteoporosis treatment |
| 01/25/2005 | US6846847 Biocidal agents and methods of use |
| 01/25/2005 | US6846846 Gentle-acting skin disinfectants |
| 01/25/2005 | US6846845 Heat shock protein inducer |
| 01/25/2005 | US6846844 (3R)-5-((2-hydroxy-4-methylphenyl)amino)-3-methyl-5-oxo-pentan oic acid, or 3,5-dichloro derivative or salts thereof; deliver active agents to selected biological systems in increased or improved bioavailability |
| 01/25/2005 | US6846843 β-thioamino acids |
| 01/25/2005 | US6846842 Organ preservation; antiischemic agents |
| 01/25/2005 | US6846841 Anti-angiogenic compositions and methods of use |
| 01/25/2005 | US6846840 Alkylating agents possessing both in vitro cytotoxicity and antitumor activity; for therapy of cancer |
| 01/25/2005 | US6846838 Ureido-substituted aniline compounds useful as serine protease inhibitors |
| 01/25/2005 | US6846837 Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| 01/25/2005 | US6846836 Administering to treat acute coronary syndrome selected from myocardial infarction, congestive heart failure, and cardiac arrhythmias |
| 01/25/2005 | US6846834 Antiinflammation agents |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846832 Highly selective monoamine oxidase B inhibitors; treating Alzheimer's disease, Parkinson's disease, and senile dementia |
| 01/25/2005 | US6846831 Method of treating the syndrome of lipodystrophy |
| 01/25/2005 | US6846830 Naphtalene derivatives and their pharmaceutical use |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | US6846824 E.g., ethyl 3-(4-(2-(3-oxo-2H-1,4-benzoxazin-4-yl)ethoxy)-phenyl-2-ethoxypropenoate where 1,4-benzothiazine or quinoxaline can be substituted for the benzoxazine ring; anticholesterol, diabetic agents; obesity; hyperlimpidemia |
| 01/25/2005 | US6846823 Method of treating lower urinary tract disorders |
| 01/25/2005 | US6846822 Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension |
| 01/25/2005 | US6846821 Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors |
| 01/25/2005 | US6846820 For therapy of diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | US6846818 Selective inhibitors of cyclooxygenase-2 |
| 01/25/2005 | US6846816 Combinations of drugs for the treatment of neoplastic disorders |
| 01/25/2005 | US6846815 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |
| 01/25/2005 | US6846811 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer |
| 01/25/2005 | US6846810 Antiviral nucleoside derivatives |
| 01/25/2005 | US6846807 Colorectal neoplasia prophylaxis |
| 01/25/2005 | US6846802 Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties |
| 01/25/2005 | US6846799 Administering epidermal growth factor antagonist; blocking with antibody; chronic obstructive pulmonary disease |
| 01/25/2005 | US6846676 In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 01/25/2005 | US6846670 Expressing heterologous nucleotide sequences in cells; obtain vascular cells, incubate with herpes virus, monitor propagation of virus in central nervous system |
| 01/25/2005 | US6846556 Titanium oxide crystal structure; vapor deposition |
| 01/25/2005 | US6846496 Postmenopause; administering estrogen; controlling dosage |
| 01/25/2005 | US6846495 Respiratory system disorders; dextromethorphan in anhydrous solvents |
| 01/25/2005 | US6846494 Aftertreatment surgery; mixture of protein, carbohydrates, fats, arginine, ascorbic acid, tocophenol and flavonoids |
| 01/25/2005 | CA2388674C Inhibitors of endo-exonuclease activity for treating cancer |
| 01/25/2005 | CA2354695C Compositions and methods for amelioration of human female sexual dysfunction |
| 01/25/2005 | CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists |
| 01/25/2005 | CA2290127C Method for the preparation of citalopram |
| 01/25/2005 | CA2228137C Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
| 01/25/2005 | CA2204769C Hemorrhoidal compositions and method of use |
| 01/25/2005 | CA2191647C Process improvement in the synthesis of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
| 01/25/2005 | CA2188981C Isomerisation of equilin |
| 01/25/2005 | CA2179377C Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 01/25/2005 | CA2169441C Effervescent system with an alkali- and/or metal-sensitive pharmaceutical active substance and process for producing the same |
| 01/25/2005 | CA2169159C Pharmaceutical composition containing a drug/.beta.-cyclodextrin complex in combination with an acid-base couple |